Abstract
Despite reducing cardiovascular disease (CVD) events and mortality in the Systolic Blood Pressure Intervention Trial (SPRINT), intensive systolic blood pressure (SBP) goals are not readily used in the US. This analysis projected long-term SBP and CVD outcomes of hypertensive treatment strategies in SPRINT-eligible US adults.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
